NCT06552624View on ClinicalTrials.gov

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
HeartburnAcid-dependent Diseases of the Gastrointestinal TractSymptomatic Treatment of Gastric and Duodenal Ulcers
Interventions
DRUG

Magaldrate

A dose of T drug in one of 2 periods of the study 2 h prior to food intake, 3 times per day

DRUG

Magaldrate

A dose of R drug in one of 2 periods of the study 2 h prior to food intake, 3 times per day

Trial Locations (3)

109235

"Llc Certa Clinic", Moscow

195271

"Private Health Care Institution Clinical Hospital RZD-Medicine of St. Petersburg", Saint Petersburg

196143

"Limited Liability Company Research Center Eco-Safety", Saint Petersburg

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY